JPS597172A - Preparation of guanidine derivative - Google Patents
Preparation of guanidine derivativeInfo
- Publication number
- JPS597172A JPS597172A JP57116167A JP11616782A JPS597172A JP S597172 A JPS597172 A JP S597172A JP 57116167 A JP57116167 A JP 57116167A JP 11616782 A JP11616782 A JP 11616782A JP S597172 A JPS597172 A JP S597172A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- guanidine
- methyl
- compound
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002357 guanidines Chemical class 0.000 title claims description 5
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 claims abstract description 19
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 7
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 150000003512 tertiary amines Chemical class 0.000 claims abstract description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 5
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 10
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 7
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 7
- -1 methylimidazol-4-yl Chemical group 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- AZGNFIUHXWRRAE-UHFFFAOYSA-N 2-cyano-1-methyl-1-(2-sulfanylethyl)guanidine Chemical compound SCCN(C)C(N)=NC#N AZGNFIUHXWRRAE-UHFFFAOYSA-N 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- WICBLRRSUUGZGC-UHFFFAOYSA-N 1-cyano-2-methyl-1-(2-sulfanylethyl)guanidine Chemical compound CNC(=N)N(C#N)CCS WICBLRRSUUGZGC-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 24
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 239000002904 solvent Substances 0.000 abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 11
- 150000001412 amines Chemical class 0.000 abstract description 8
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 abstract description 4
- 208000025865 Ulcer Diseases 0.000 abstract description 2
- 238000005804 alkylation reaction Methods 0.000 abstract description 2
- 238000005580 one pot reaction Methods 0.000 abstract description 2
- 231100000397 ulcer Toxicity 0.000 abstract description 2
- 230000029936 alkylation Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- AXJZCJSXNZZMDU-UHFFFAOYSA-N (5-methyl-1h-imidazol-4-yl)methanol Chemical compound CC=1N=CNC=1CO AXJZCJSXNZZMDU-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OXPFWTHSDWUOEZ-UHFFFAOYSA-N 1-[(5-methyl-1h-imidazol-4-yl)methyl]piperidine Chemical compound N1C=NC(CN2CCCCC2)=C1C OXPFWTHSDWUOEZ-UHFFFAOYSA-N 0.000 description 1
- GAPFINWZKMCSBG-UHFFFAOYSA-N 2-(2-sulfanylethyl)guanidine Chemical compound NC(=N)NCCS GAPFINWZKMCSBG-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- CBPYOHALYYGNOE-UHFFFAOYSA-M potassium;3,5-dinitrobenzoate Chemical compound [K+].[O-]C(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 CBPYOHALYYGNOE-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- GYBMSOFSBPZKCX-UHFFFAOYSA-N sodium;ethanol;ethanolate Chemical compound [Na+].CCO.CC[O-] GYBMSOFSBPZKCX-UHFFFAOYSA-N 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】 本発明は式 で表わされるグアニジン誘導体の新規な製法に関する。[Detailed description of the invention] The present invention is based on the formula This invention relates to a new method for producing a guanidine derivative represented by:
更に詳しくは9式
〔式中R”、R”およびR3は同一または異なって低級
アルキル基、低級アルケニル基もしくはアラルキル基を
示し、またR1およびR3は隣接する窒素原子と共に異
項環を形成してもよい。More specifically, formula 9 [wherein R", R" and R3 are the same or different and represent a lower alkyl group, a lower alkenyl group or an aralkyl group, and R1 and R3 together with the adjacent nitrogen atom form a heterocyclic ring] Good too.
Qは酸残基を示す〕で表わされる四級アンモニウム塩に
N−シアノ−N′−メチル−N’−(2−メルカプトエ
チル)グアニジンを反応させてN−シアノ−N′−メチ
ル−N’ −(2−((5−メチルイミダゾール−4−
イル)メチルチオ〕エチル)グアニジンを得ることを特
徴とする式(I)の化合物の製法、 および4−メチ
ルイミダゾールに一般式
%式%(1)
〔式中R1およびR11は前記の意味を有する〕で表わ
されるアミン類およびホルムアルデヒドを反応させて一
般式
〔式中R1およびR2は前記の意味を有する〕で表わさ
れる三級アミンを得、これに一般式%式%()
〔式中R3およびQは前記の意味を有する〕で表わされ
るアルキル化剤を反応させて一般式〔式中R’ 、 R
” 、 R3およびQは前記の意味を有する〕で表わさ
れる四級アンモニウム塩を得。Q represents an acid residue] is reacted with N-cyano-N'-methyl-N'-(2-mercaptoethyl)guanidine to form N-cyano-N'-methyl-N'. -(2-((5-methylimidazole-4-
yl)methylthio]ethyl)guanidine, and 4-methylimidazole with the general formula % (1) [wherein R1 and R11 have the abovementioned meanings] An amine represented by the formula % and formaldehyde are reacted to obtain a tertiary amine represented by the general formula [wherein R1 and R2 have the above-mentioned meanings], and a tertiary amine represented by the general formula % formula % ( ) [wherein R3 and Q has the above-mentioned meaning] to react with an alkylating agent represented by the general formula [wherein R', R
” , R3 and Q have the above-mentioned meanings].
次いでこれにN−シアノ−N′−メチル−N′−(2−
メルカプトエチル)グアニジンを反応させてN−シアノ
−N′−メチル−N’−(2−((5−メチル、イミダ
ゾール−4−イル)メチルチオ〕エチル)グアニジンを
得ることを特徴とする式(1)の化合物の製法に関する
ものである。This was then added with N-cyano-N'-methyl-N'-(2-
Formula (1) characterized in that N-cyano-N'-methyl-N'-(2-((5-methyl, imidazol-4-yl)methylthio]ethyl)guanidine is obtained by reacting mercaptoethyl)guanidine. ) relates to a method for producing the compound.
式(1)で表わされるグアニジン誘導体はヒスタミン■
、−受容体拮抗作用を有し 潰瘍治療のための医薬品と
して有用な化合物である。The guanidine derivative represented by formula (1) is histamine ■
, - It is a compound that has receptor antagonistic action and is useful as a drug for treating ulcers.
従来式(I)の化合物の製法としていくつかの方法(4
!開昭49− ’75114 、同51−545451
および同51−125014号等)が提案されているが
。Conventionally, there are several methods (4) for producing the compound of formula (I).
! 1977-'75114, 51-545451
and No. 51-125014, etc.) have been proposed.
これらはいずれも原料化合物として4−ヒドロキシメチ
ル−5−メチルイミダゾールまたはそれから誘導される
化合物を使用している。All of these use 4-hydroxymethyl-5-methylimidazole or a compound derived therefrom as a raw material compound.
しかしこの4−ヒドロキシメチル−5−メチルイミダゾ
ールは、簡単な製造法がないため入手が困難な化合物で
ある。 またシメチジンの公知の諸製法には、この他
にも複数個の反応ガマを必要とする操作の煩雑さ、低収
率による精製の困難さ、大過剰のメチルアミンの使用に
よる製造コストの上昇等の多くの問題点が残されている
。However, this 4-hydroxymethyl-5-methylimidazole is a compound that is difficult to obtain because there is no easy manufacturing method. In addition, known production methods for cimetidine have other problems such as complicated operations requiring multiple reaction vessels, difficulty in purification due to low yields, and increased production costs due to the use of a large excess of methylamine. Many problems remain.
今回本発明者ら屹 この式(1)の化合物の別途合成法
について種々検討を重ねた結果9次に示すような新規な
合成ルートを開発した。The present inventors have conducted various studies on separate methods for synthesizing the compound of formula (1), and as a result, have developed a new synthetic route as shown below.
〔式中R1、R11l 、 R3およびQは前記の意味
を有する〕本発明は上記の工程(C)、および(A)→
(B)→(0)に関するものであシ、4−ヒドロキシメ
チルー5−メチルイミダゾールの使用が避けられるなど
の点で従来の製法に比較して有利である。[In the formula, R1, R11l, R3 and Q have the above-mentioned meanings] The present invention provides the above steps (C) and (A)→
Regarding (B)→(0), it is advantageous compared to conventional production methods in that the use of 4-hydroxymethyl-5-methylimidazole can be avoided.
本発明によれば尚該目的化合物(1)は、一般式(I[
)で表わされる四級アンモニウム塩にN−シアノーN′
−メチル−N’ −(2−メルカプトエチル)グアニジ
ン(■)を反応させることによシ製造される。 さら
に一般式(It)の四級塩は。According to the present invention, the target compound (1) has the general formula (I[
) to the quaternary ammonium salt represented by N-cyano N'
-Methyl-N'-(2-mercaptoethyl)guanidine (■). Furthermore, the quaternary salt of general formula (It) is.
4−メチルイミダゾール(VI)に一般式(1)で表わ
されるアミン類およびホルムアルデヒドヲ作用させて9
、一般式(IV)で表わされる三級アミンを得、これに
一般式(V)で表わされるアルキル化剤を作用させるこ
とにより得られる。By reacting 4-methylimidazole (VI) with amines represented by general formula (1) and formaldehyde, 9
, is obtained by obtaining a tertiary amine represented by general formula (IV) and allowing an alkylating agent represented by general formula (V) to act thereon.
本発明における各一般式の化合物を説明すると2式中の
R1,R”およびR3で表わされる置換基は、同一また
は異なって低級アルキル基、低級アルケニル基もしくは
アラルキル基を示し、具体的にはメチル基、エチル基、
プロピル基、イソプロピル基、アリル基、クロチル基、
ベンジル基等の基を意味している。 またこのうちR
1およびtは互いに連結して隣接する窒素原子と共に異
頃環を形成してもよく、その具体例にはピロリジン、ピ
ペリジンあるいはモルホリンなどの環がある。 さら
にQは酸残基を示し。To explain the compounds of each general formula in the present invention, the substituents represented by R1, R'' and R3 in formula 2 are the same or different and represent a lower alkyl group, a lower alkenyl group, or an aralkyl group, and specifically, methyl group, ethyl group,
Propyl group, isopropyl group, allyl group, crotyl group,
It means a group such as a benzyl group. Of these, R
1 and t may be linked to each other to form a heterocyclic ring with the adjacent nitrogen atom, specific examples of which include rings such as pyrrolidine, piperidine and morpholine. Furthermore, Q represents an acid residue.
具体的には塩素、臭素もしくはヨウ素または硫酸モジく
はアルキルスルホン酸などの酸残基を意味している。Specifically, it refers to acid residues such as chlorine, bromine, iodine, sulfate, alkylsulfonic acid, and the like.
本発明の(C)の工程を実施するに際しては。When implementing step (C) of the present invention.
一般式(n)で表わされる四級アンモニウム塩と式(■
)のメルカプタンを1反応に関与しない溶媒中で、好ま
しくは塩基の存在下に反応させる。Quaternary ammonium salt represented by general formula (n) and formula (■
) are reacted in a solvent that does not participate in the reaction, preferably in the presence of a base.
この反応に使用される溶媒は極性の有機溶媒が好ましく
9例えばメタノール、エタノール。The solvent used in this reaction is preferably a polar organic solvent9, such as methanol or ethanol.
インプロパツール等の低級アルコールが適当である。
反応は通常、四級塩(II)に対して当モル以上の塩
基の存在下に行われ、その塩基としては例えば水酸化ナ
トリウム、水酸化カリウム、ナトリウムメトキシド、ナ
トリウムエトキシド等が適している。Lower alcohols such as Impropatool are suitable.
The reaction is usually carried out in the presence of a base in an amount equivalent to or more than the equivalent mole of the quaternary salt (II), and suitable bases include sodium hydroxide, potassium hydroxide, sodium methoxide, sodium ethoxide, etc. .
反応温度および反応時間は特に制限されないが。Although the reaction temperature and reaction time are not particularly limited.
普通は室温付近の温度で数時間反応するのが便利である
。It is usually convenient to react at a temperature around room temperature for several hours.
次に本発明のもう一つの特徴として、4−メチルイミダ
ゾール(Vl)を出発原料とする工程(A)のマンニッ
ヒ反応および工程(B)のアルキル化反応により前記の
四級アンモニウム塩(II)を得。Next, as another feature of the present invention, the quaternary ammonium salt (II) can be prepared by the Mannich reaction in step (A) and the alkylation reaction in step (B) using 4-methylimidazole (Vl) as a starting material. Profit.
続いてこれを工程(0)で式(■)のメルカプタンと反
応させて目r的化合物(1)を得る製法がある。Subsequently, in step (0), this is reacted with a mercaptan of formula (■) to obtain the target compound (1).
この反応の実施に際しては、まず4−メチルイミダゾー
ル(Vl)に反応対応量のアミン類(1)およびホルム
アルデヒドを1反応に関与しない溶媒中、好ましくは5
0〜100Cの加温下に反応させる。 この反応に
使用される溶媒としては水、低級アルコールまたは酢酸
等の極性溶媒が適当である。 また使用されるアミン
類(1)はその遊離塩基もしくはその塩酸塩等が用いら
れ、またホルムアルデヒドとしてはその水溶液もしくは
パラホルムアルデヒド等が用いられる。When carrying out this reaction, first, 4-methylimidazole (Vl) is mixed with reaction-corresponding amounts of amines (1) and formaldehyde in a solvent that does not participate in the reaction, preferably 5
The reaction is carried out under heating at 0 to 100C. As the solvent used in this reaction, polar solvents such as water, lower alcohols or acetic acid are suitable. The amine (1) used is its free base or its hydrochloride, and the formaldehyde used is its aqueous solution or paraformaldehyde.
次に、上記の反応により得られた式(IV)の三級アミ
ンと反応対応量のアルキル化剤(V)を。Next, the tertiary amine of formula (IV) obtained by the above reaction and the alkylating agent (V) in an amount corresponding to the reaction.
反応に関与しない溶媒中で冷却または加温下に反応させ
る。 使用される溶媒としては例えば低級アルコール
、アセトン、クロロホルム。The reaction is carried out under cooling or heating in a solvent that does not participate in the reaction. Examples of solvents used include lower alcohols, acetone, and chloroform.
ジオキサンまたはジメチルホルムアミド等が適当である
。Dioxane or dimethylformamide are suitable.
続いて、上記の反応により得られた式(II)の四級ア
ンモニウム塩と式(■)のメルカプタンを反応させるが
、この反応は前記と同様な条件下に行うことができる。Subsequently, the quaternary ammonium salt of formula (II) obtained by the above reaction is reacted with the mercaptan of formula (■), and this reaction can be carried out under the same conditions as described above.
前記したこれらの反応は通常溶媒中で行われ。These reactions described above are usually carried out in a solvent.
その溶媒としてはいずれの場合もメタノール。The solvent used in both cases is methanol.
エタノールなどの低級アルコール類が適シティる。
このため必要に応じて中和のための塩基などを追加する
と、上記の連続工程を全て同一の溶媒中で行うことも可
能である。Lower alcohols such as ethanol are suitable.
For this reason, if a base or the like for neutralization is added as necessary, it is also possible to carry out all of the above continuous steps in the same solvent.
本発明の製法によシ得られた式(1)の化合物は常法に
よシ単離精製される。 本製法における目的物の収率
は一般に’70〜95チと高く。The compound of formula (1) obtained by the production method of the present invention is isolated and purified by conventional methods. The yield of the target product in this production method is generally as high as '70-95.
また反応の全工程が緩和な条件下に、しかもワンポット
で行えることなどを考慮すれば2本発明は工業的製法と
して非常に有利な方法である。Furthermore, considering that all the reaction steps can be carried out under mild conditions and in one pot, the present invention is a very advantageous industrial production method.
以下に実施例を挙げ1本発明を具体的に説明する。The present invention will be specifically explained below with reference to Examples.
実施例1
金属ナトリウム0.5Ofと無水メタノール50rnt
から調整したナトリウムメトキシドメタノール溶液に、
窒素零囲気下N−シアノーN′−メチル−N’−(2−
メルカプトエチル)グアニジン3.2fを加えて室温で
5分間攪拌する。 この液にN−(5−メチルイミ
ダゾール−4−イル)メチル−N、N、N−)リメチル
アンモニウムアイオダイド6.04fを数回に分けて3
0分間で加え。Example 1 Metallic sodium 0.5Of and anhydrous methanol 50rnt
Sodium methoxide methanol solution prepared from
N-cyano N'-methyl-N'-(2-
Add 3.2 f of (mercaptoethyl) guanidine and stir at room temperature for 5 minutes. Add 6.04f of N-(5-methylimidazol-4-yl)methyl-N,N,N-)limethylammonium iodide to this solution in several portions.
Added in 0 minutes.
室温でさらに1時間攪拌する。 35%塩酸を加えて
過剰のナトリウムメトキシドを中和後。Stir for an additional hour at room temperature. After neutralizing excess sodium methoxide by adding 35% hydrochloric acid.
溶媒を減圧留去し、残有をクロロホルム:メタノール;
10:1を溶出溶媒とするシリカゲルカラムクロマトグ
ラフィーで精製する。 溶出液を蒸発後、残有をアセ
トニ) IJルから再結晶するとN−シアノ−N−メチ
ル−N’−(2−((5−メチルイミダゾール−4−イ
ル)メチルチオ〕エチル)グアニジン4.86S+(収
率89.7%)が得られる。 融点 141−142
C0本品は標品と混融して融点降下を示さず、赤外吸収
スペクトルおよび薄層クロマトグラフィーは標品と完全
に一致する。The solvent was distilled off under reduced pressure, and the residue was dissolved in chloroform:methanol;
Purify by silica gel column chromatography using 10:1 as an elution solvent. After evaporation of the eluate, the residue is recrystallized from IJ. (yield 89.7%).Melting point 141-142
C0 This product mixes with the standard product and shows no drop in melting point, and its infrared absorption spectrum and thin layer chromatography completely match the standard product.
実施例2
4−メチルイミダゾール2.005’、 ピペリジン
塩酸塩6.0OS’および317%ホルマリン2.16
Fヲエタノール20−に加えて3時間加熱還流する。Example 2 4-methylimidazole 2.005', piperidine hydrochloride 6.0OS' and 317% formalin 2.16
F was added to 20% of ethanol and heated under reflux for 3 hours.
溶媒を減圧留去後残有を水に溶解し、炭酸カリウムを加
えて中和した後クロロホルムで抽出する 抽出液を
蒸発後残有をベンゼン−ヘキサンから再結晶すると4−
ピペリジノメチル−5−メチルイミダゾール4.0C1
(収率91.6チ)が得られる。 融点 162−
164 C0上記の生成物4.0Orをメタノール40
−に溶解し、ヨウ化メチル4.8C1を加えて室温に2
0時間放置する。 メタノールと過剰のヨウ化メチル
を留去し、残有をイソプロピルアルコール−ヘキサンか
ら再結晶するとN−(5−メチルイミダゾール−4−イ
ル)メチル−N−メチルピペリジウムアイオダイド6.
80 r (収率94.8%)が得られる。 融点
13’7−139 t:’ 0上記の四級塩3.40S
’を、メタノール3o−に水酸化ナトリウム0.55
fおよびN−シアノ−「−メチル−N’−(2−メルカ
プトエチル)グアニジン1.50Fを溶解した液に加え
、室温で2時間攪拌する。 35%塩酸を加えて過剰
のアルカリを中和後、溶媒を減圧乾固し、残有を熱イソ
プロピルアルコールに溶解する。 不溶の無機塩を戸
別後、P液を減圧乾固し、残有を熱アセトニトリルに溶
解する。 アセトニトリル溶液を炭末で処理後、氷
室に一夜放置するとN−シアノ〜N′−メチル−N’−
(2−1:(5−メチルイミダゾール−4−イル)メチ
ルチオ〕エチル)グアニジン2.16 t (収率85
.1%)が得られる。 融点 139−14100
実施例3・
4−メチルイミダゾール2.05f、 ジエチルアミ
ン塩酸塩2.471およびパラホルムアルデヒド0、’
i’6 tをエタノール2o−に加えて4時間加熱還流
する。After evaporating the solvent under reduced pressure, the residue is dissolved in water, neutralized with potassium carbonate, and extracted with chloroform. After evaporating the extract, the residue is recrystallized from benzene-hexane to obtain 4-
Piperidinomethyl-5-methylimidazole 4.0C1
(Yield 91.6 cm) is obtained. Melting point 162-
164 C0 4.0 Or of the above product in methanol 40
-, add 4.8C1 of methyl iodide and bring to room temperature for 2 hours.
Leave it for 0 hours. Methanol and excess methyl iodide were distilled off, and the residue was recrystallized from isopropyl alcohol-hexane to yield N-(5-methylimidazol-4-yl)methyl-N-methylpiperidium iodide 6.
80 r (yield 94.8%) is obtained. melting point
13'7-139 t:' 0 Above quaternary salt 3.40S
', methanol 3o- to sodium hydroxide 0.55
f and N-cyano-'-methyl-N'-(2-mercaptoethyl)guanidine 1.50F dissolved in the solution and stirred at room temperature for 2 hours. After neutralizing excess alkali by adding 35% hydrochloric acid. , the solvent is dried under reduced pressure and the residue is dissolved in hot isopropyl alcohol. After removing the insoluble inorganic salts, the P solution is dried under reduced pressure and the residue is dissolved in hot acetonitrile. The acetonitrile solution is treated with charcoal powder. After that, if you leave it in an ice room overnight, N-cyano~N'-methyl-N'-
(2-1:(5-methylimidazol-4-yl)methylthio]ethyl)guanidine 2.16 t (yield 85
.. 1%) is obtained. Melting point 139-14100 Example 3 4-methylimidazole 2.05f, diethylamine hydrochloride 2.471 and paraformaldehyde 0,'
Add i'6t to ethanol 2o- and heat under reflux for 4 hours.
反応液を水冷後、2Nナトリウムエトキシドエタノール
溶液1.25−を加え1次いで析出した無機塩を戸別後
、ヨウ化メチル3.55f’を加えて室温に一夜放置す
る。After the reaction solution was cooled with water, 1.25% of a 2N sodium ethoxide ethanol solution was added thereto, the precipitated inorganic salt was separated, 3.55f' of methyl iodide was added, and the mixture was left at room temperature overnight.
エタノール50−に金属ナトリウム0.659およびN
−シアノ−N′−メチル−N’ −(2−メルカプトエ
チル)グアニジン3.’?’3Fを溶解し、この液に室
温攪拌下上記の反応液を30分間を要して滴下する。
室温で2時間攪拌後、溶媒を減圧留宍し、残有をクロ
ロホルム:メタノール−40:1を溶出溶媒とするシリ
カゲルカラムクロマトグラフィーによシ精製する。
溶出液を蒸発後、残有をアセトニトリルから再結晶すれ
ばN−シアノ−N′−メチル−N′〜(2−1m(5−
メチルイミダゾール−4−イル)メチルチオ〕エチル)
グアニジン4.6+71F(収率ツ4.1%)が得られ
る。 融点 ユ40−1!2C0特許出願人 萬有
製薬株式会社
633−Ethanol 50- to 0.659-metal sodium and N
-Cyano-N'-methyl-N'-(2-mercaptoethyl)guanidine3. '? '3F was dissolved, and the above reaction solution was added dropwise to this solution over a period of 30 minutes while stirring at room temperature.
After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using chloroform:methanol-40:1 as an eluent.
After evaporating the eluate, the residue is recrystallized from acetonitrile to give N-cyano-N'-methyl-N'~(2-1m(5-
methylimidazol-4-yl)methylthio]ethyl)
Guanidine 4.6+71F (yield: 4.1%) is obtained. Melting point: Yu40-1!2C0 Patent applicant: Banyu Pharmaceutical Co., Ltd. 633-
Claims (2)
アルキル基、低級アルケニル基もしくはアラルキル基を
示し、またR1およびR2は隣接する窒素原子と共に異
項環を形成してもよい。 Qは酸残基を示す〕で表
わされる四級アンモニウム塩にN−シアノ−N′−メチ
ル−N−(2−メルカプトエチル)グアニジンを反応さ
せてN−シアノ−N′−メチル−N“−(2−((5−
メチルイミダゾール−4−イル)メルカプトエチル)グ
アニジンを得ることを特徴とするグアニジン誘導体の製
法。(1) Formula [In the formula, R1, R2 and R3 are the same or different and represent a lower alkyl group, a lower alkenyl group or an aralkyl group, and R1 and R2 may form a heterocyclic ring together with the adjacent nitrogen atom. Q represents an acid residue] is reacted with N-cyano-N'-methyl-N-(2-mercaptoethyl)guanidine to form N-cyano-N'-methyl-N"- (2-((5-
A method for producing a guanidine derivative, characterized in that methylimidazol-4-yl)mercaptoethyl)guanidine is obtained.
ル基、低級アルケニル基もしくはアラルキル基を示し、
また両者は隣接する窒素原子と共に異項環を形成しても
よい〕で表わされるアミン類およびホルムアルデヒドヲ
反応させて式 〔式中R1およびR2は前記の意味を有する〕で表わさ
れる三級アミンを得、これに式〔式中R3は低級アルキ
ル基、低級アルクニル基まだはアラルキル基を示し、Q
は酸残基を示す〕で表わされるアルキル化剤を反応させ
て式 〔式中H1,R11、R3およびQは前記の意味を有す
る〕で表わされる四級アンモニウム塩ヲ得1次いでこれ
にN−シアノ−N′−メチル−N’−(2−メルカプト
エチル)グアニジンを反応させてN−シアノ−N′−メ
チル−N′−(2−((5−メチルイミダゾール−4−
イル)メチルチオ〕エチル)グアニジンを得ることを特
徴とするグアニジン誘導体の製法。(2) 4-methylimidazole with the formula [wherein R1 and R2 are the same or different and represent a lower alkyl group, a lower alkenyl group, or an aralkyl group,
Both may form a heterocyclic ring together with adjacent nitrogen atoms] and formaldehyde are reacted to form a tertiary amine represented by the formula [wherein R1 and R2 have the above-mentioned meanings]. This was obtained by formula [wherein R3 represents a lower alkyl group, a lower alknyl group, or an aralkyl group, and Q
represents an acid residue] to obtain a quaternary ammonium salt represented by the formula [where H1, R11, R3 and Q have the above-mentioned meanings]. Cyano-N'-methyl-N'-(2-mercaptoethyl)guanidine was reacted to form N-cyano-N'-methyl-N'-(2-((5-methylimidazole-4-
A method for producing a guanidine derivative, characterized in that guanidine is obtained.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57116167A JPS597172A (en) | 1982-07-06 | 1982-07-06 | Preparation of guanidine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57116167A JPS597172A (en) | 1982-07-06 | 1982-07-06 | Preparation of guanidine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS597172A true JPS597172A (en) | 1984-01-14 |
Family
ID=14680440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57116167A Pending JPS597172A (en) | 1982-07-06 | 1982-07-06 | Preparation of guanidine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS597172A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
-
1982
- 1982-07-06 JP JP57116167A patent/JPS597172A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1044241A (en) | Imidazoline derivatives and the preparation thereof | |
IE48829B1 (en) | Production of triazinones | |
US4650892A (en) | Process for the preparation of herbicidal sulfonamides | |
SU950188A3 (en) | Process for producing derivatives of 4(5)-mercaptomethylimidazoles | |
JPS5845429B2 (en) | benzoguanamine derivatives | |
JPS597172A (en) | Preparation of guanidine derivative | |
Finch et al. | Syntheses of 1, 2, 4-benzothiadiazine 1-oxides and 1, 2, 4-benzothiadiazines | |
US3398155A (en) | 2, 6-dichloro-isonicotinamide derivatives and a method for their preparation | |
JPS5834473B2 (en) | 1,2,4↓-oxadiazole derivative | |
HU176328B (en) | Process for preparing isothiocarbamide derivatives | |
JPH0144708B2 (en) | ||
US3461131A (en) | Process for preparing 2-substituted cycloheptimidazole derivatives | |
JPS6317837B2 (en) | ||
JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
US3112316A (en) | Z-o-chlohobenzylmercapto-x-dimethyl- | |
JP2580477B2 (en) | Method for producing 5-pyrazole mercaptan derivative and intermediate thereof | |
DE19814801A1 (en) | Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts | |
JPH08208591A (en) | 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates | |
JP2565372B2 (en) | Method for producing thiol compound | |
PL164340B1 (en) | Method of obtaining novel benzothiazine derivatives | |
EP0036684A1 (en) | Derivatives of 4-methyl-5-(2-aminoethyl)-thiomethyl-imidazole having therapeutic activity | |
JPH0623180B2 (en) | Cyanoguanidine derivative and method for producing the same | |
HU190087B (en) | Process for preparing 3-phenyl-pyrrole derivatives | |
JPH04139170A (en) | Substituted pyridinesufonylcarbamate-based compound, its production and production of substituted pyridinesulfonamide-based compound | |
HU195485B (en) | Process for producing aromatic carboxylic acid derivatives and -carboxamide derivatives |